Announcements Trials
Browse Landscape

Phase

Phase 4 4

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Esophageal Neoplasms 4

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × sodium glycididazole × Gastrointestinal × Clear all
NCT02721550 2019-10-11

A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC

Shandong Cancer Hospital and Institute

Phase 4 Terminated
2 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02721563 2019-10-11

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

Shandong Cancer Hospital and Institute

Phase 4 Completed
77 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02721576 2019-10-11

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

Shandong Cancer Hospital and Institute

Phase 4 Terminated
8 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00642239 2008-05-14

A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

Shandong Luye Pharmaceutical Co., Ltd.

Phase 4 Unknown
48 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡